Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. (RANI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RANI · as of Jun 9, 2026
Key Statistics
Explore Rani Therapeutics Holdings, Inc. Data
rani stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
The RANI analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $15.67, representing +1766.36% upside from the current price of $0.84.
Competitors & Peers
rani competitorsRANI
APLT
CRBP
CRDF
CYBN
ELTXStock Performance
Full HistoryAbout Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. functions as a clinical-stage biopharmaceutical enterprise focused on revolutionizing the delivery of biologic therapies through oral administration. Its flagship inno…
what is rani therapeutics holdings, inc. · rani stock overview · rani therapeutics holdings, inc. company profile · who is rani therapeutics holdings, inc. ceo · rani NASDAQ · rani therapeutics holdings, inc. headquarters · rani therapeutics holdings, inc. business segments
About Stock Overview & Key Data
Rani Therapeutics Holdings, Inc. (RANI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 30, 2021. As of the latest trading session, RANI stock price is $0.84, with a market capitalization of $54.8M. The stock has returned +46.25% over the past 12 months and -37.81% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Rani Therapeutics Holdings, Inc. stock is Buy, with an average 12-month price target of $15.67. In fiscal year 2025, Rani Therapeutics Holdings, Inc. reported revenue of $1.6M and net income of -$29.7M. For detailed data — including Rani Therapeutics Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Rani Therapeutics Holdings, Inc. (RANI) stock price is $0.84. The stock is traded on NASDAQ under the ticker symbol RANI. The 52-week range is $0.39 – $3.87.